History of Real-World Evidence Prior to the 21st Century Cures Act
Medical Affairs thought leaders discuss the Pre-21st Century Cures Act uses of Real World Evidence (RWE) in regulatory decision-making.
This author has not written his bio yet.
But we are proud to say that Medical Affairs contributed 191 entries already.
Medical Affairs thought leaders discuss the Pre-21st Century Cures Act uses of Real World Evidence (RWE) in regulatory decision-making.
The Series Podcast Objectives are:
Podcast objectives include understanding how the medical affairs strategic planning process can drive decision making throughout the year
Medical Affairs thought leaders discuss the function, activities and opportunities for compliant collaboration with key internal partners.
Nothing could stand between Joseph Eid and his dream of becoming a doctor—not even gunfire.
Cerise James, MD, moderates this podcast in which Neil Belson, JD, discusses Real World Evidence and its impact to the biopharmaceutical industry.
Real-World Evidence can show safety and effectiveness per FDA’s “totality of evidence approach” for evaluating regulatory submissions.
This Medical Affairs Professional Society (MAPS) podcast features medical affairs thought leaders offering insights into the Medical Affairs strategic planning process
Murali Gopal, MD, discusses the power of Integrated Brand Planning to transform the Medical Affairs function within the biopharmaceutical industry
Sawyer is making it her life’s work to focus on the patient—the most important stakeholder in drug development.
MAPS speaks with Beat Sümegi, SVP Medical with Sanofi, about major areas of change and the need to help Medical Affairs professionals build new skills to succeed in this world of increased responsibility and opportunity.